- £836.55m
- £1.14bn
- £712.80m
Annual cashflow statement for CVS, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 25.7 | 41.9 | 6.4 | 53 | 17.8 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 29.7 | 21.5 | 41.2 | -1.1 | 35.2 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -27.5 | -29.3 | -38.3 | -34.3 | -46.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 75.5 | 84.5 | 67.8 | 82.1 | 71.3 |
| Capital Expenditures | -24.5 | -45.7 | -43.1 | -34.2 | -36.4 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -20.6 | -54.2 | -97.4 | 11.5 | -43 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -45.1 | -99.9 | -141 | -22.7 | -79.4 |
| Financing Cash Flow Items | — | -3.6 | -0.9 | -0.2 | -4.8 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -15.1 | -12.1 | 68.3 | -59.2 | 10.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 15.3 | -27.5 | -5 | -0.4 | 2.3 |